Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Humana stock in Canada | $419.18
Own Humana shares in just a few minutes.
Humana (HUM) is a leading healthcare plans business based in the US. It opened the day at $422.1 after a previous close of $420.96. During the day the price has varied from a low of $416.51 to a high of $421.93. The latest price was $419.18 (25 minute delay). Humana is listed on the NYSE and employs 43,000 staff. All prices are listed in US Dollars.
How to buy Humana stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: HUM in this case.
- Research Humana stocks. The platform should provide the latest information available.
- Buy your Humana stocks. It's that simple.
What's in this guide?
- Can I buy shares in Humana?
- Has coronavirus impacted Humana shares?
- Humana shares summary
- Compare share dealing platforms
- Is Humana stock a buy or sell?
- Humana performance over time
- Can I short Humana shares?
- Is Humana suitable for ethical investing?
- Are Humana shares over-valued?
- Humana's financials
- How volatile are Humana shares?
- Does Humana pay a dividend?
- Have Humana shares ever split?
- Other common questions
How has Coronavirus impacted Humana's stock price?
Since the stock market crash in March caused by coronavirus, Humana's stock price has had significant positive movement.
Its last market close was $426.33, which is 13.29% up on its pre-crash value of $369.67 and 104.72% up on the lowest point reached during the March crash when the stocks fell as low as $208.25.
If you had bought $1,000 worth of Humana stocks at the start of February 2020, those stocks would have been worth $643.29 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,278.99.
Humana stock priceUse our graph to track the performance of HUM stocks over time.
Humana stocks at a glance
|52-week range||$362.7262 - $475.44|
|50-day moving average||$445.316|
|200-day moving average||$413.4445|
|Wall St. target price||$492.95|
|Dividend yield||$2.575 (0.61%)|
|Earnings per share (TTM)||$28.152|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Humana stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Humana price performance over time
|1 week (2021-06-07)||0.76%|
|1 month (2021-05-14)||-7.41%|
|3 months (2021-03-12)||3.11%|
|6 months (2020-12-11)||7.17%|
|1 year (2020-06-12)||10.68%|
|2 years (2019-06-13)||64.56%|
|3 years (2018-06-13)||36.80%|
|5 years (2016-06-13)||126.96%|
Is Humana under- or over-valued?
Valuing Humana stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Humana's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Humana's P/E ratio
Humana's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Humana stocks trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stocks or simply that they're under-valued.
Humana's PEG ratio
Humana's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4607. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Humana's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Humana's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$5.4 billion.
The EBITDA is a measure of a Humana's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$78.9 billion|
|Operating margin TTM||6.51%|
|Gross profit TTM||USD$15.5 billion|
|Return on assets TTM||8.91%|
|Return on equity TTM||28.04%|
|Market capitalisation||USD$54.5 billion|
TTM: trailing 12 months
How to short and sell Humana stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "HUM.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 1.5 million Humana stocks held short by investors – that's known as Humana's "short interest". This figure is 17% down from 1.8 million last month.
There are a few different ways that this level of interest in shorting Humana stocks can be evaluated.
Humana's "short interest ratio" (SIR)
Humana's "short interest ratio" (SIR) is the quantity of Humana stocks currently shorted divided by the average quantity of Humana stocks traded daily (recently around 786798.41269841). Humana's SIR currently stands at 1.89. In other words for every 100,000 Humana stocks traded daily on the market, roughly 1890 stocks are currently held short.
However Humana's short interest can also be evaluated against the total number of Humana stocks, or, against the total number of tradable Humana stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Humana's short interest could be expressed as 0.01% of the outstanding stocks (for every 100,000 Humana stocks in existence, roughly 10 stocks are currently held short) or 0.0115% of the tradable stocks (for every 100,000 tradable Humana stocks, roughly 12 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Humana.
Find out more about how you can short Humana stock.
Humana's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Humana.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Humana's total ESG risk score
Total ESG risk: 25.71
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Humana's overall score of 25.71 (as at 01/01/2019) is pretty good – landing it in it in the 33rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Humana is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Humana's environmental score
Environmental score: 2.6/100
Humana's environmental score of 2.6 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Humana's social score
Social score: 18.54/100
Humana's social score of 18.54 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Humana's governance score
Governance score: 5.07/100
Humana's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Humana is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Humana's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Humana scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Humana has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||25.71|
|Total ESG percentile||32.96|
|Environmental score percentile||3|
|Social score percentile||3|
|Governance score percentile||3|
|Level of controversy||2|
Humana stock dividends
Dividend payout ratio: 12.61% of net profits
Recently Humana has paid out, on average, around 12.61% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.66% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Humana shareholders could enjoy a 0.66% return on their shares, in the form of dividend payments. In Humana's case, that would currently equate to about $2.575 per share.
While Humana's payout ratio might seem low, this can signify that Humana is investing more in its future growth.
Humana's most recent dividend payout was on 30 July 2021. The latest dividend was paid out to all shareholders who bought their stocks by 29 June 2021 (the "ex-dividend date").
Have Humana stocks ever split?
Humana stocks were split on a 3:2 basis on 1 August 1991. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Humana stocks – just the quantity. However, indirectly, the new 33.3% lower stock price could have impacted the market appetite for Humana stocks which in turn could have impacted Humana's stock price.
Humana stock price volatility
Over the last 12 months, Humana's stocks have ranged in value from as little as $362.7262 up to $475.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while Humana's is 0.8826. This would suggest that Humana's stocks are less volatile than average (for this exchange).
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Frequently asked questions
More on investing
Find out about gold ETFs, what influences their prices, how you can trade them and whether they could be worth your weight in gold.Read more…
Impact investing is perhaps the purest form of responsible investing. Want to know why? Read our guide to find out.Read more…
Find out what a short squeeze is and how to trade a short squeeze. We’ve detailed how they work, some examples and the high risks involved.Read more…
More guides on Finder
How to buy Atara Biotherapeutics (ATRA) stock in Canada | $14.40
Steps to owning and managing ATRA, with 24-hour and historical pricing before you buy.
How to buy Alnylam Pharmaceuticals (ALNY) stock in Canada | $165.02
Steps to owning and managing ALNY, with 24-hour and historical pricing before you buy.
How to buy Zogenix (ZGNX) stock in Canada | $18.20
Steps to owning and managing ZGNX, with 24-hour and historical pricing before you buy.
How to buy Voyager Therapeutics (VYGR) stock in Canada | $4.73
Steps to owning and managing VYGR, with 24-hour and historical pricing before you buy.
How to buy Vornado Realty Trust (VNO) stock in Canada | $50.01
Steps to owning and managing VNO, with 24-hour and historical pricing before you buy.
How to buy Salem Media Group (SALM) stock in Canada | $2.60
Steps to owning and managing SALM, with 24-hour and historical pricing before you buy.
How to buy HireQuest (HQI) stock in Canada | $20.46
Steps to owning and managing HQI, with 24-hour and historical pricing before you buy.
How to buy Brady (BRC) stock in Canada | $59.52
Steps to owning and managing BRC, with 24-hour and historical pricing before you buy.
How to buy Accelerate Diagnostics (AXDX) stock in Canada | $8.75
Steps to owning and managing AXDX, with 24-hour and historical pricing before you buy.
How to buy Univar Solutions (UNVR) stock in Canada | $27.56
Steps to owning and managing UNVR, with 24-hour and historical pricing before you buy.